Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and
SAN DIEGO, April 25, 2013
SAN DIEGO, April 25, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a
life sciences company providing innovative diagnostic testing and genetic
analysis solutions, today announced it will report financial results for the
first quarter of 2013 after closing of the NASDAQ Global Market on Thursday,
May 9, 2013.
A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and
other members of senior management will take place on the same day at 5:00 pm
ET (2:00 pm PT) and will be webcast live on the Sequenom website.
To access the live teleconference call, dial 800-860-2442 in the U.S. and
412-858-4600 for international callers. Please specify to the operator that
you would like to join the "Sequenom First Quarter 2013 Earnings Conference
Call." If you are unable to listen to the live webcast, a teleconference
replay will be available until Friday, May 17, 2013. Interested parties can
access the replay by dialing 877-344-7529 or 412-317-0088 internationally and
entering the conference number 10028207.
The conference call webcast is accessible through the "Investors" section of
the Sequenom website at http://ir.sequenom.com. An online replay will be
available following the initial broadcast until Friday, May 17, 2013.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genetic analysis solutions.
Sequenom develops innovative technology, products and diagnostic tests that
target and serve discovery and clinical research, and molecular diagnostics
markets. The company was founded in 1994 and is headquartered in San Diego,
California. Sequenom maintains a Web site at http://www.sequenom.com to which
Sequenom regularly posts copies of its press releases as well as additional
information about Sequenom. Interested persons can subscribe on the Sequenom
Web site to email alerts or RSS feeds that are sent automatically when
Sequenom issues press releases, files its reports with the Securities and
Exchange Commission or posts certain other information to the Web site.
SOURCE Sequenom, Inc.
Contact: Marcy Graham, Senior Director, Investor Relations & Corp Comm,
Sequenom, Inc., 858-202-9028, email@example.com, or Jakob Jakobsen, Media
Contact, Chandler Chicco Agency, 310-309-1003,
Press spacebar to pause and continue. Press esc to stop.